Newsletter
| Promoter: | Small Cap Leader | Paying Party: | Star Media |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| XXII | $15000 | 1961507 |
| Max Profit: 17.83 % | Gain at close: 1.55 % |
Our records indicate that xxxxxx@gmail.com requested to be added to SmallCapLeader.com on Jun. 3, 2015. Click Here To Unsubscribe
New Alert: 22nd Century Group, Inc. (NYSE: XXII)
http://www.xxiicentury.com/
Last Close: $1.22
Good Morning!
22nd Century Group, Inc.(XXII) is our new Biotech Alert trading on the NYSE. XXII is a plant biotechnology company with a very important mission: To Reduce the Harm Caused by Smoking. XXII closed yesterday at $1.22 and we believe this company has very strong upside potential.
XXII currently owns or controls more than 185 issued patents and more than an additional 54 pending patent applications around the world. One of XXII's proprietary tobacco varieties contains 97% LESS nicotine than tobacco in leading cigarette brands.
In 2013, XXII signed an exclusive worldwide research licensing agreement with British American Tobacco(BAT) granting access to a portion of their patented technology through a 4-year research license agreement with an option to enter into a commercial license. BAT is one of the world's largest producers and distributors of tobacco products and have operations in over 180 countries throughout the world. BAT(NYSE:BTI) is a giant company with an approximate market cap of $102 billion.
Under terms of the agreement with BAT, XXII granted BAT research rights to three of its patent families spreading across 34 patents and patent applications in various countries and regions. Importantly, XXII retained worldwide rights to the licensed technology and patents licensed to BAT for use worldwide by XXII in its products and brands. The agreement also has an option to enter into a worldwide commercial license with XXII in the future. If this option is exercised, it would be very significant as that would extend a new licensing agreement to at least the year 2028.
The BAT agreement could also potentially result in a royalty-bearing commercial licence in 2016 and then would have the potential to sub-license the products co-developed with BAT to other major tobacco companies in a profit split.
XXII already produces a commercially-available cigarette called MAGIC SILVER that has approximately 95% less nicotine than other leading cigarettes previously marketed as “light” prior to The Family Smoking Prevention and Tobacco Control Act of 2009.
XXII is also currently developing two modified risk cigarettes. Since the Tobacco Control Act of 2009, the U.S. FDA now regulates tobacco products and cigarette products can no longer use terms like "light", "ultra-light", "low tar", or "all natural". To make these types of claims, tobacco manufacturers must file applications with the U.S. FDA for review and approval. The application must contain clinical data supporting the modified risk claim.
XXII is in the process right now of filing an application with the U.S. FDA for Brand-A, and is expected to be the first tobacco manufacturer to obtain a modified risk claim for its commercially available VLN cigarettes in the U.S. We believe this to be a major catalyst as research suggests that approximately 90% of smokers would be willing to try a new brand if it were "safer" than their usual brand.
Before being banned in 2009, "light" cigarettes had more than 80% of the market. Approximately one billion consumers spend $700 billion each year on tobacco products worldwide. A product like XXII's Brand-A with a modified risk claim has very strong potential to be a very big product. XXII is also working on a second modified risk cigarette, Brand-B, which is a low tar-to-nicotine cigarette.
On top of this, XXII is developing a prescription smoking cessation aid called X-22 that tastes, smells, and smokes like a conventional cigarette. X-22 is a kit containing very low nicotine (VLN) cigarettes that is going through the FDA-approval process as a prescription smoking cessation aid.
On November 24th, XXII announced that it will open specialized laboratories in Western New York dedicated to new scientific research at substantially lower costs than sponsored research projects at third-party universities.
XXII also announced Q3 2015 results on November 9th. The Company continued to grow revenues during the third quarter of 2015 through sales of RED SUN premium cigarettes, contract manufacturing of a third-party MSA cigarette brand, continued contract manufacturing of filtered cigars, and continued sales of MAGIC “0.0mg nicotine” cigarettes in Europe. Net revenues were approximately $2,668,000 in Q3 and net revenues for the first nine months of 2015 in the amount of $5,591,000 continued to exceed previously announced revenue expectations and were significantly higher than revenues of approximately $529,000 for the entire year of 2014.
As you can see, XXII has a very strong portfolio with many catalysts on the horizon that could make a significant impact on the growing $3 billion smoking-cessation market.
Get started on your research now and stay tuned for more..
Sincerely, Small Cap Leader Follow us on Twitter @SmallCapLeader for faster alerts and real time updates.
For Quicker Alerts Text Keyword "Stocks" to 24587 to Receive our SMS Mobile Alerts!
You are receiving this email because you signed up to our free alert newsletter. If you want to unsubscribe, Click Here To Unsubscribe
Notice and Disclaimer-Please Read Carefully
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. SmallCapLeader.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by SmallCapLeader.com or an offer or solicitation to buy or sell any security. Neither the owner of SmallCapLeader.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit SmallCapLeader.com. SmallCapLeader.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. Third parties and/or affiliates of SmallCapLeader.com may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. SmallCapLeader.com has been compensated fifteen thousand dollars by a third party(Star Media LLC) for an investor awareness campaign regarding XXII. Any compensation received constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.
Notice of Stock Price Movements and Volatility. Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week. Some of the content in this release contains forward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and the Financial Industry Regulatory Authority ("FINRA") website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. SmallCapLeader.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and SmallCapLeader.com Network has no obligation to update any of the information provided. SmallCapLeader.com its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. SmallCapLeader.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. SmallCapLeader.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does SmallCapLeader.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that SmallCapLeader.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that SmallCapLeader.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. SmallCapLeader.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold SmallCapLeader.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. SmallCapLeader.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.
Questions regarding any information contained in this report may be sent to info@SmallCapLeader.com. To review Small Cap Leader’s website and its disclaimer, please visit www.SmallCapLeader.com.
|
PO Box 31431
Charleston SC 29417
USA
Unsubscribe | Change Subscriber Options
Charleston SC 29417
USA
Unsubscribe | Change Subscriber Options